MARKET

RVNC

RVNC

Revance Therapeu
NASDAQ
3.680
+0.410
+12.54%
After Hours: 3.690 +0.01 +0.27% 19:53 01/17 EST
OPEN
3.660
PREV CLOSE
3.270
HIGH
3.700
LOW
3.600
VOLUME
11.24M
TURNOVER
--
52 WEEK HIGH
7.56
52 WEEK LOW
2.300
MARKET CAP
386.04M
P/E (TTM)
-1.8917
1D
5D
1M
3M
1Y
5Y
1D
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Benzinga · 2d ago
Needham Reiterates Hold on Revance Therapeuticsto Hold
Benzinga · 2d ago
Hold Rating Recommended Amid Competitive Bidding War for Revance Therapeutics
TipRanks · 2d ago
Crown Labs Proposed Higher Revance Bid to Save Deal
Dow Jones · 2d ago
Revance Therapeutics soars after Crown Labs raises offer to $3.65 a share
Seeking Alpha · 2d ago
Hold Rating for Revance Therapeutics Amid Acquisition Uncertainty and Competing Bids
TipRanks · 4d ago
Evolus: Still Bullish, But Business Faces Tricky Challenges In '25
Seeking Alpha · 5d ago
Revance Therapeutics: The Takeover Saga Continues As Teoxane Enters The Fray
Seeking Alpha · 5d ago
More
About RVNC
Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to commercialize DAXXIFY in China. Its product/product candidate includes DAXXIFY for glabellar lines indication; DAXXIFY for cervical dystonia indication; RHA Redensity for perioral rhytids indication; RHA 2/ RHA 3/ RHA 4 for facial wrinkles and folds (such as nasolabial folds) indication; DAXXIFY for forehead lines, lateral canthal lines, upper facial lines indication; DAXXIFY for upper limb spasticity indication, and onabotulinumtoxinA biosimilar. The Company has exclusive right to import, market, promote, sell and distribute Teoxane's line of Resilient Hyaluronic Acid dermal fillers.

Webull offers Revance Therapeutics Inc stock information, including NASDAQ: RVNC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVNC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVNC stock methods without spending real money on the virtual paper trading platform.